Month: May 2020

Herved følger offentliggørelsesdatoer for Bang & Olufsens planlagte selskabsmeddelelser til NASDAQ Copenhagen A/S, herunder også datoer for generalforsamlinger i 2020 og 2021. Delårsrapporter og årsrapport vil blive offentliggjort de anførte datoer om morgenen.2020Onsdag 3. juni                 Ekstraordinær generalforsamlingTirsdag 7. juli                   Årsrapport 2019/20Torsdag 20. august         Generalforsamling                                        (Seneste frist for emner til dagsordenen er 9. juli)Torsdag 1. oktober          Delårsrapport (1. kvartal 2020/21)2021Tirsdag 12. januar           Delårsrapport (2. kvartal 2020/21)Torsday 8. april               Delårsrapport (3. kvartal 2020/21)Onsdag 7. juli                  Årsrapport 2020/21Torsdag 19. august         Generalforsamling                                       ...

CHARLOTTE, N.C., May 25, 2020 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that it will participate in the Stifel 2020 Jaws and Paws Conference on May 27th.Don Casey, Chief Executive Officer, will represent the company and is scheduled to participate in a fireside chat at 4:45PM Eastern Time.  Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting www.dentsplysirona.com.  A replay of the presentation will also be available on the Dentsply Sirona website at www.dentsplysirona.com.About Dentsply SironaDentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 132-year history of innovation and service to the dental industry and patients worldwide. ...

SAN FRANCISCO, May 25, 2020 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera“) today issued the following letter to shareholders from the Company’s President and CEO, Robert Farrell.Dear Kalytera Shareholders,I would like to underscore the importance of the transaction that we announced last week, and provide an update on our programs in prevention and treatment of graft versus host disease and in treatment of pain.On Tuesday last week, we announced that Kalytera has signed a Letter of Intent to acquire Salzman Group, Inc. (“Salzman Group”).  On close of this transaction, Kalytera will have a new pharmaceutical development program, developing R-107 for three indications, including treatment of COVID-19 associated lung disease, chlorine inhalation...

TORONTO, May 25, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its highly anticipated and innovative suite of “Ace Valley Vapes” are officially available in several markets across Canada.   The Company shipped three new vape products under this white label brand-line to multiple provinces last week.The launch of the Ace Valley Vapes is the culmination of the Company’s previously announced white label agreement through its subsidiary, MediPharm Labs Inc., with AV Cannabis Inc. (d/b/a Ace Valley). Through this collaboration, Ace Valley leveraged its leading brand traction and product strategy expertise...

Leiden, Netherlands & Cambridge, Mass., May 25, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced that the Annual General Meeting of Shareholders will take place on Tuesday, June 23, 2020 at 15:00 CET, via videoconference.All relevant documents and information for the meeting, including the notice and agenda, are or will be made available in the “Investors” section of ProQR’s website (www.proqr.com) under “Financial Information”. The documents will also be made available on the SEC’s website at www.sec.gov.  Shareholders that wish to attend the videoconference should register for attendance as described in the notice and agenda, after which they will receive...

Key points: Biology of Blood and Marrow Transplantation, the official publication of the American Society for Transplantation and Cellular Therapy, publishes three peer-reviewed articles detailing results from three separate trials of remestemcel-L in children and adults with acute graft versus host diseasePublications highlight consistent benefits seen across all three trials in patients with greatest levels of inflammation and the most severe grades of the disease Trial results underpin Mesoblast’s Biologics License Application to seek approval of its product candidate RYONCIL™ (remestemcel-L) for pediatric steroid-refractory acute graft versus host disease (GVHD), which has been accepted for priority review by the United States Food and Drug Administration (FDA)These outcomes also provide the rationale for use of remestemcel-L in other...

Highlights:EarthRenew has developed and produced five new fertilizer formulations for field trials and market development activities this springThe fertilizer formulations incorporate biochar, provided by BiocharNow, as well as insect frassTORONTO, May 25, 2020 (GLOBE NEWSWIRE) — EarthRenew Inc. (CSE:ERTH) (“EarthRenew” or the “Company”) is pleased to announce that it has developed and produced five new formulations of fertilizer pellets, incorporating insect frass and biochar.  We intend to test these new formulations in the field trial programs scheduled to take place this spring in collaboration with Olds College and Lethbridge College (see the Company’s press release dated April 29, 2020, which is available under EarthRenew’s SEDAR profile at www.sedar.com and www.theCSE.com). EarthRenew worked with BiocharNow, LLC (“BiocharNow”)...

TORONTO, May 25, 2020 (GLOBE NEWSWIRE) — Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) announces that, further to its news release dated May 11, 2020, it has decided to no longer pursue the acquisition of all of the issued and outstanding common shares of Guyana Goldfields Inc.  As a result, Gran Colombia and Gold X Mining Corp. (“Gold X”) have agreed to terminate the Plan of Arrangement between Gran Colombia and Gold X dated May 11, 2020.About Gran Colombia Gold Corp.Gran Colombia is a Canadian-based mid-tier gold producer with its primary focus in Colombia where it is currently the largest underground gold and silver producer with several mines in operation at its high-grade Segovia Operations. Gran Colombia owns approximately 74% of Caldas Gold Corp., a Canadian mining company currently advancing a prefeasibility study for...

Montreal, Quebec,, May 25, 2020 (GLOBE NEWSWIRE) — Montreal, Quebec, May 25th, 2020 – SRG Mining Inc. (TSXV: SRG) (“SRG” or the “Company”) today provides an update on recent activities related to its Lola graphite project (the “Project”).The Company has recently signed its 5th offtake agreement for 10,000 tonnes per year for a three-year period. This brings the total signed off-take agreements to 128,000t over three years. These agreements represent approximately 85% of the Company’s anticipated production over that period. Our clients operate in various markets including refractories, expandable graphite and battery anode material. We remain actively engaged with several potential clients to continue to sign off-take agreements for our graphite production.The Company continues to believe in signing sales agreements for the anticipated...

VANCOUVER, British Columbia, May 25, 2020 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received from Health Canada its cannabis cultivation and sales licence based on an initial production area within its second 1.1 million square foot greenhouse facility in Delta, British Columbia (the “Delta 2 facility”), allowing it to expand capacity as needed through successive license amendments. The Delta 2 facility is adjacent to its established, fully operating 1.1 million square foot Delta 3 greenhouse facility and, when in production, is expected to contribute to further lowering Pure Sunfarms’ already industry leading cost of cultivation.On the heels of the leading market share...